Abeona Therapeutics Inc.
ABEO
$5.83
-$0.02-0.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -209.86% | 249.68% | 211.69% | 215.93% | 208.83% |
| Total Depreciation and Amortization | 19.51% | 20.65% | 22.57% | 13.85% | 6.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.07% | -951.23% | -1,684.39% | -898.59% | -3,085.33% |
| Change in Net Operating Assets | -441.78% | 31.42% | -22.91% | -1,944.02% | 173.08% |
| Cash from Operations | -15.86% | -29.81% | -36.26% | -53.89% | -56.34% |
| Capital Expenditure | 4.24% | -140.52% | -226.04% | -295.74% | -250.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -116.47% | 569.95% | 406.97% | 372.16% | 408.76% |
| Cash from Investing | -119.92% | 488.75% | 367.66% | 345.45% | 392.09% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -61.53% | -77.59% | -69.55% | -68.17% | -79.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.81% | 98.90% | 97.52% | 85.33% | 59.28% |
| Cash from Financing | -85.55% | -80.05% | -74.99% | -73.90% | -82.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -183.37% | 2,880.52% | 516.19% | 509.75% | 357.82% |